191 related articles for article (PubMed ID: 23200303)
1. Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial.
Walsh SL; Middleton LS; Wong CJ; Nuzzo PA; Campbell CL; Rush CR; Lofwall MR
Drug Alcohol Depend; 2013 Jun; 130(1-3):150-7. PubMed ID: 23200303
[TBL] [Abstract][Full Text] [Related]
2. Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals.
Passamonti L; Luijten M; Ziauddeen H; Coyle-Gilchrist ITS; Rittman T; Brain SAE; Regenthal R; Franken IHA; Sahakian BJ; Bullmore ET; Robbins TW; Ersche KD
Psychopharmacology (Berl); 2017 Aug; 234(15):2289-2297. PubMed ID: 28551713
[TBL] [Abstract][Full Text] [Related]
3. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.
Somoza EC; Winship D; Gorodetzky CW; Lewis D; Ciraulo DA; Galloway GP; Segal SD; Sheehan M; Roache JD; Bickel WK; Jasinski D; Watson DW; Miller SR; Somoza P; Winhusen T
JAMA Psychiatry; 2013 Jun; 70(6):630-7. PubMed ID: 23575810
[TBL] [Abstract][Full Text] [Related]
4. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.
Kampman KM; Lynch KG; Pettinati HM; Spratt K; Wierzbicki MR; Dackis C; O'Brien CP
Drug Alcohol Depend; 2015 Oct; 155():105-10. PubMed ID: 26320827
[TBL] [Abstract][Full Text] [Related]
5. Safety of atomoxetine in combination with intravenous cocaine in cocaine-experienced participants.
Cantilena L; Kahn R; Duncan CC; Li SH; Anderson A; Elkashef A
J Addict Med; 2012 Dec; 6(4):265-73. PubMed ID: 22987022
[TBL] [Abstract][Full Text] [Related]
6. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
Kelsey DK; Sumner CR; Casat CD; Coury DL; Quintana H; Saylor KE; Sutton VK; Gonzales J; Malcolm SK; Schuh KJ; Allen AJ
Pediatrics; 2004 Jul; 114(1):e1-8. PubMed ID: 15231966
[TBL] [Abstract][Full Text] [Related]
7. A randomized placebo-controlled trial of gabapentin for cocaine dependence.
Bisaga A; Aharonovich E; Garawi F; Levin FR; Rubin E; Raby WN; Nunes EV
Drug Alcohol Depend; 2006 Feb; 81(3):267-74. PubMed ID: 16169160
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.
Weisler RH; Pandina GJ; Daly EJ; Cooper K; Gassmann-Mayer C;
CNS Drugs; 2012 May; 26(5):421-34. PubMed ID: 22519922
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
[TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence.
Reid MS; Casadonte P; Baker S; Sanfilipo M; Braunstein D; Hitzemann R; Montgomery A; Majewska D; Robinson J; Rotrosen J
Addiction; 2005 Mar; 100 Suppl 1():43-57. PubMed ID: 15730349
[TBL] [Abstract][Full Text] [Related]
11. Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.
Jordan CJ; Harvey RC; Baskin BB; Dwoskin LP; Kantak KM
Drug Alcohol Depend; 2014 Jul; 140():25-32. PubMed ID: 24811203
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence.
Winhusen T; Somoza E; Sarid-Segal O; Goldsmith RJ; Harrer JM; Coleman FS; Kahn R; Osman S; Mezinskis J; Li SH; Lewis D; Afshar M; Ciraulo DA; Horn P; Montgomery MA; Elkashef A
Drug Alcohol Depend; 2007 Dec; 91(2-3):205-12. PubMed ID: 17628352
[TBL] [Abstract][Full Text] [Related]
13. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.
Shoptaw S; Yang X; Rotheram-Fuller EJ; Hsieh YC; Kintaudi PC; Charuvastra VC; Ling W
J Clin Psychiatry; 2003 Dec; 64(12):1440-8. PubMed ID: 14728105
[TBL] [Abstract][Full Text] [Related]
14. Double-blind evaluation of homeopathy on cocaine craving: a randomized controlled pilot study.
Adler UC; Acorinte AC; Calzavara FO; da Silva AA; de Toledo Cesar A; Adler MS; Martinez EZ; Galduróz JCF
J Integr Med; 2018 May; 16(3):178-184. PubMed ID: 29625852
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects.
DeVito EE; Herman AI; Konkus NS; Zhang H; Sofuoglu M
Pharmacol Biochem Behav; 2017 Aug; 159():55-61. PubMed ID: 28716656
[TBL] [Abstract][Full Text] [Related]
16. [Atomoxetine (Strattera), an alternative in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children].
Gaillez C; Sorbara F; Perrin E
Encephale; 2007 Sep; 33(4 Pt 1):621-8. PubMed ID: 18033153
[TBL] [Abstract][Full Text] [Related]
17. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.
Spencer T; Heiligenstein JH; Biederman J; Faries DE; Kratochvil CJ; Conners CK; Potter WZ
J Clin Psychiatry; 2002 Dec; 63(12):1140-7. PubMed ID: 12523874
[TBL] [Abstract][Full Text] [Related]
18. [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
Purper-Ouakil D; Fourneret P; Wohl M; Rénéric JP
Encephale; 2005; 31(3):337-48. PubMed ID: 16142049
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.
Baldaçara L; Cogo-Moreira H; Parreira BL; Diniz TA; Milhomem JJ; Fernandes CC; Lacerda AL
J Clin Psychiatry; 2016 Mar; 77(3):398-406. PubMed ID: 27046312
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.
Mooney ME; Herin DV; Schmitz JM; Moukaddam N; Green CE; Grabowski J
Drug Alcohol Depend; 2009 Apr; 101(1-2):34-41. PubMed ID: 19058926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
